Display options
Share it on

Mitochondrion. 2004 Aug;4(4):331-8. doi: 10.1016/j.mito.2004.07.031.

Terminal oxidation and the effects of zinc in prostate versus liver mitochondria.

Mitochondrion

Leslie C Costello, Zhixin Guan, Boone Kukoyi, Pei Feng, Renty B Franklin

Affiliations

  1. Department of Biomedical Sciences, Dental School--University of Maryland, 666 West Baltimore Street, Baltimore, MD 21201, USA. [email protected]

PMID: 16120396 PMCID: PMC4464835 DOI: 10.1016/j.mito.2004.07.031

Abstract

Although the total zinc content of cells generally approximates 0.2 mM, the cytosolic free zinc ion concentration is negligible (subnanomolar concentrations). However, all reported studies of effects of zinc on cellular respiration and terminal oxidation involved microM-mM levels of free zinc ions. Prostate cells and their mitochondria accumulate 3-10 fold more zinc than other mammalian cells. We considered that a cytosolic pool of mobile reactive low molecular weight zinc ligands could inhibit respiration and terminal oxidation. The effects of ZnLigands, especially ZnCitrate, versus free Zn++ ions on respiration and terminal oxidation were studied with prostate and liver mitochondria. ZnLigands were equally as effective as free Zn++ ions in the inhibition of respiration and terminal oxidation of both prostate and liver mitochondria, which supports our concept that zinc can be transferred from cytosolic donor ZnLigands directly to zinc-binding sites of terminal oxidation components. Also, the respiration and specific activities of terminal oxidation components of prostate mitochondria are 20-50% of liver mitochondria. Zinc inhibition and inherently low levels of electron transport components are likely major factors responsible for the low respiration that characterizes prostate cells.

References

  1. J Biol Chem. 1995 Oct 20;270(42):25001-6 - PubMed
  2. Biochem Biophys Res Commun. 1967 Jan 10;26(1):1-6 - PubMed
  3. J Biol Chem. 1955 Sep;216(1):357-69 - PubMed
  4. Prostate Cancer Prostatic Dis. 2004;7(2):111-7 - PubMed
  5. J Biol Chem. 1997 Nov 14;272(46):28875-81 - PubMed
  6. Eur J Biochem. 1991 Apr 23;197(2):555-61 - PubMed
  7. J Biol Chem. 1971 Feb 25;246(4):1160-7 - PubMed
  8. Physiol Rev. 1993 Jan;73(1):79-118 - PubMed
  9. Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2317-22 - PubMed
  10. Biochemistry. 1968 Jan;7(1):305-10 - PubMed
  11. Oncology. 2000 Nov;59(4):269-82 - PubMed
  12. J Inorg Biochem. 2003 Oct 1;97(2):199-206 - PubMed
  13. Prostate. 1998 Jun 1;35(4):285-96 - PubMed
  14. Am J Physiol. 1953 Mar;172(3):588-600 - PubMed
  15. Science. 2001 Jun 29;292(5526):2488-92 - PubMed
  16. Endocr Res. 1984;10(2):171-81 - PubMed
  17. Anal Biochem. 1976 May 7;72:248-54 - PubMed
  18. FEBS Lett. 1972 Feb 1;20(2):229-232 - PubMed
  19. Prostate. 1997 Jan 1;30(1):26-32 - PubMed
  20. J Reprod Fertil. 1983 Jul;68(2):359-63 - PubMed
  21. J Steroid Biochem. 1981 Oct;14(10):1075-84 - PubMed

Publication Types

Grant support